Diagnos Laboratorium Utama Tbk. vs Goodyear Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Goodyear Indonesia Tbk. trades at Rp1,080 (market cap 453.05B, 2.7K 24h volume). The key difference: Goodyear Indonesia Tbk. is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 2.7K). Which is the better fit depends on your goals.
| DGNS | GDYR | |
|---|---|---|
Market Cap | 310.75B | 453.05B |
Volume | 963.6K | 2.7K |
Lot | 9.64K | 27 |
Turnover | 217.67M | 2.97M |
Average Price | 225.89 | 1,100.74 |
Value | 217.67M | 2.97M |
Indicative Equilibrium Price | 226 | — |
Indicative Equilibrium Volume | 1K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Goodyear Indonesia Tbk (the Company) was established on January 6, 1917 under the name “NV The Goodyear Tire & Rubber Company Limited” and changed its name to “PT Goodyear Indonesia” on July 25, 1978. On November 10, 1980, the Company obtained approval from the Capital Market Supervisory Board (BAPEPAM) to offer a portion of its shares to the public through the Indonesia Stock Exchange. Effective December 22, 1980, 6,150,000 shares of the Company with total par value of Rp 6,150,000 (equivalent to 15% of the total issued and outstanding shares) were officially listed in Jakarta Stock Exchange.
Read more on GDYR →